Invion Ltd has released a press release.
Further Information on Proof of Concept Pilot Study
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Invion
- Complete Regression of TNBC Tumours and Protective Immunity
- Capital Raising & co-development for Photosoft Technology
- Initial Proof-of-Concept results show INV043 to be effective
- App 4D and Financial Report for half year to 31 Dec 2020
- Business Update and Change to Board and Management
Later from Invion
- Capital Raising and expansion of Photosoft Territory
- Share Purchase Plan Offer Booklet & Application Form
- Prospectus
- Supplementary Prospectus
- INV043 significantly improved checkpoint inhibitor therapy
Follow Invion into a list and get an email when it puts out news.
Follow Invion